Irritable Bowel Syndrome study: Inulin
Official title Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
ClinicalTrials.gov ID: NCT06668922
What this study is testing
- What it's testing
- This study is testing whether changes in gut bacteria and their waste products are linked to IBS symptoms.
- Who it's for
- You may be able to join if you are 18‑65, have IBS or are a healthy person without symptoms.
- What's involved
- You will eat a high‑fat diet for four days and give stool samples on the last two days. You will also fill out a bowel diary.
- Time commitment
- The study lasts about a week with a few visits to give samples and complete questionnaires.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Age 18-75
- Individuals with irritable bowel syndrome (IBS)
- Healthy volunteers (healthy controls) with no prior history of gastrointestinal (GI) disease or symptoms
- No dietary restrictions other than vegetarian
You likely can't join if
- Inflammatory bowel disease, celiac disease, or certain types of abdominal cancer, as well as those with thyroid or liver issues
- Abdominal surgery or abdominal radiation within 6 months of study participation, with an exception for C-section or gallbladder removal
- Use of any prescription, over the counter, or herbal medications known to affect gastrointestinal function or study interpretation, such as opioids...
- An exception will be permitted for limited use of stable low doses of antidepressants for individuals who have been taking them for a period greater...
- Rescue medication such as Bisacodyl (dulcolax) to relieve severe constipation and allow for stool collection will be permitted when needed.
- Use of Ozempic and Ozempic-type medications
See the full eligibility criteria
- Age 18-75
- Individuals with irritable bowel syndrome (IBS)
- Healthy volunteers (healthy controls) with no prior history of gastrointestinal (GI) disease or symptoms
- No dietary restrictions other than vegetarian
- Inflammatory bowel disease, celiac disease, or certain types of abdominal cancer, as well as those with thyroid or liver issues
- Abdominal surgery or abdominal radiation within 6 months of study participation, with an exception for C-section or gallbladder removal
- Use of any prescription, over the counter, or herbal medications known to affect gastrointestinal function or study interpretation, such as opioids, inflammatory drugs or certain antidepressants, within 6 months prior...
- An exception will be permitted for limited use of stable low doses of antidepressants for individuals who have been taking them for a period greater than one month.
- Rescue medication such as Bisacodyl (dulcolax) to relieve severe constipation and allow for stool collection will be permitted when needed.
- Use of Ozempic and Ozempic-type medications
- Pregnant or breastfeeding women
- Antibiotic use within 3 months of study participation
- Use of prebiotics or probiotics within the 2 weeks before the study initiation
- Regular tobacco use within the past 6 months
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.